These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 9926262)

  • 1. An important drug interaction.
    Williams CN
    Can J Gastroenterol; 1998; 12(8):535. PubMed ID: 9926262
    [No Abstract]   [Full Text] [Related]  

  • 2. Consultation-liaison psychiatry drug--drug interactions update.
    Armstrong SC; Cozza KL; Cole MA
    Psychosomatics; 2000; 41(4):375-6. PubMed ID: 10906369
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between fluconazole and midazolam in intensive care patients.
    Ahonen J; Olkkola KT; Takala A; Neuvonen PJ
    Acta Anaesthesiol Scand; 1999 May; 43(5):509-14. PubMed ID: 10341997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St. John's Wort: not so safe.
    Chase SL
    RN; 2000 Nov; 63(11):114. PubMed ID: 11147004
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of fibric acid derivatives.
    Spence JD
    Clin Pharmacokinet; 1998 May; 34(5):419-20. PubMed ID: 9592623
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug effects: new information about an old problem.
    Miller CA
    Geriatr Nurs; 2001; 22(6):336-7. PubMed ID: 11780009
    [No Abstract]   [Full Text] [Related]  

  • 7. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
    Kunze KL; Wienkers LC; Thummel KE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):414-21. PubMed ID: 8801056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride interaction with antidepressants.
    Caley C
    Ann Pharmacother; 1996 Jun; 30(6):684. PubMed ID: 8792962
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1997 Sep; 39(1009):86-8. PubMed ID: 9305292
    [No Abstract]   [Full Text] [Related]  

  • 10. The need for multiple doses of 400 mg ketoconazole as a precipitant inhibitor of a CYP3A substrate in an in vivo drug-drug interaction study.
    Oo C; Chen YC
    J Clin Pharmacol; 2009 Mar; 49(3):368-9; author reply 370. PubMed ID: 19246734
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor.
    Hoover WC; Britton LJ; Gardner J; Jackson T; Gutierrez H
    Ann Pharmacother; 2011 Jul; 45(7-8):e38. PubMed ID: 21712512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions and the cytochrome P-450 system.
    Menke JJ
    S D J Med; 2000 Jun; 53(6):231-2. PubMed ID: 10901063
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in related drug class utilization after market withdrawal of cisapride.
    Glessner MR; Heller DA
    Am J Manag Care; 2002 Mar; 8(3):243-50. PubMed ID: 11915974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions.
    Med Lett Drugs Ther; 1999 Jul; 41(1056):61-2. PubMed ID: 10436770
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment: possible interaction between nefazodone and pravastatin.
    Bottorf MB
    Ann Pharmacother; 2000 Apr; 34(4):538, 541. PubMed ID: 10772447
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic drug monitoring in methadone maintenance: choosing a matrix.
    Moolchan ET; Umbricht A; Epstein D
    J Addict Dis; 2001; 20(2):55-73. PubMed ID: 11318398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
    Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
    Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically significant cytochrome P-450 drug interactions--a comment.
    Ford NF; Sonnichsen DS
    Pharmacotherapy; 1998; 18(4):890-1; discussion 892-3. PubMed ID: 9692671
    [No Abstract]   [Full Text] [Related]  

  • 20. The human CYP3A subfamily: practical considerations.
    Wrighton SA; Schuetz EG; Thummel KE; Shen DD; Korzekwa KR; Watkins PB
    Drug Metab Rev; 2000; 32(3-4):339-61. PubMed ID: 11139133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.